 ALEMTUZUMAB, FLUDARABINE PHOSPHATE, AND TOTAL-BODY IRRADIATION FOLLOWED BY CYCLOSPORINE AND MYCOPHENOLATE MOFETIL IN TREATING PATIENTS WHO ARE UNDERGOING DONOR STEM CELL TRANSPLANT FOR HEMATOLOGIC CANCER: 